T47.1X6
Underdosing of other antacids and anti-gastric-secretion drugs
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T47.1X6 refers to cases where individuals do not take their prescribed or recommended doses of antacids and anti-gastric secretion medications adequately. These drugs are commonly used to manage conditions involving excess stomach acid, such as gastroesophageal reflux disease (GERD), peptic ulcers, and gastritis. Underdosing can lead to insufficient symptom control and potentially worsen health outcomes. Recognizing the importance of correct medication use is essential for effective treatment and health maintenance.
Causes & Symptoms
Clinical Causes: Lack of understanding about the importance of medication dosing Forgetfulness or poor medication adherence Concern over potential side effects or adverse reactions Financial constraints that limit the purchase of medication Complex medication regimens leading to confusion Perceived improvement of symptoms leading to premature discontinuation Difficulty swallowing pills or other physical barriers
Key Symptoms: Persistent or returning symptoms of acid reflux, such as heartburn and chest discomfort Regurgitation of stomach acid into the esophagus Increased frequency of indigestion or discomfort after meals Possible development of complications like esophageal inflammation if underdosed over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves reviewing patient medication history and adherence patterns. Healthcare providers may perform clinical assessments and request medication refill records. In some cases, additional testing such as endoscopy, pH monitoring, or imaging studies may be used to evaluate the degree of acid suppression and the presence of related complications.
Treatment Protocols: Addressing underdosing involves patient education about the importance of compliance and proper medication usage. Healthcare professionals may adjust medication dosages or formulations if necessary. Strategies to improve adherence include reminder systems, simplified dosing schedules, and addressing any barriers to access. No specific medical intervention is indicated solely for underdosing, but ongoing medical evaluation ensures optimal disease management.
Clinical Advice & FAQs
Billing Guidance
Is T47.1X6 a billable ICD-10 code?
Yes, T47.1X6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T47.1X6?
Clinical documentation must specify the nature of Underdosing of other antacids and anti-gastric-secretion drugs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
